Name (Synonyms) | Correlation | |
---|---|---|
drug682 | Ravulizumab Wiki | 1.00 |
drug114 | Best Supportive Care Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D055370 | Lung Injury NIH | 0.32 |
D011024 | Pneumonia, Viral NIH | 0.17 |
D055371 | Acute Lung Injury NIH | 0.16 |
D013577 | Syndrome NIH | 0.15 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.15 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.13 |
D011014 | Pneumonia NIH | 0.08 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Biological collection (blood sample) associated with clinical data from Covid-19 patients
Description: Clinical aggravation markers (admission in intensive care)
Measure: Phenotype/genotype correlation research modulating the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Severity at the Covid-19 Lung Scanner
Measure: Phenotype/transcriptomic correlation research modulating the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Severity at the Covid-19 Lung Scanner
Measure: Phenotype/biomarker correlation research modulating the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Evolution of scanographic lesions or pulmonary ultrasound
Measure: Development of clinical-biological scores in the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Evolution of scanographic lesions or pulmonary ultrasound
Measure: Development of predictive imaging scores in the severity of Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Duration of oxygen therapy, artificial ventilation
Measure: Identification of pathophysiological pathways to susceptibility to Covid-19 disease Time: Anytime in the period of 10 yearsDescription: Genome sequencing
Measure: Identification of genetic markers for treatment response Time: Anytime in the period of 10 yearsDescription: Sequencing transcriptome
Measure: Identification of transcriptomic markers for treatment response Time: Anytime in the period of 10 yearsDescription: Proteomic sequencing
Measure: Identification of proteomic for treatment response Time: Anytime in the period of 10 years